Claude

IntuitionLabs is now a member of the Claude Partner Network – AI training and upskilling with Claude for pharma and biotech. Book a call.

IntuitionLabs
Life sciences delivery evidence and implementation proof

Proof with the Evidence Boundary Visible

Verified client work, sourced public research, and implementation evidence are different forms of proof. We label them clearly and never turn confidential engagement details into public claims without permission.

Three kinds of evidence

Buyers should be able to tell what was delivered for a named client, what was learned from public sources, and what describes our operating method.

Client
Verified Delivery Case
A named commercial analytics implementation with client-approved facts, quotation, platform context, and a detailed delivery narrative.
Read the Scilex case study
Research
Public Market Evidence
A source-linked review of reported GenAI implementations across pharma and biotech. This is independent research, not IntuitionLabs client work.
Open the research report
Method
AI Acceleration Model
Our implementation approach for governed information, department workflows, adoption, and measurement. Service design is not presented as a client outcome.
Explore the operating model

Our public-proof standard

Life-sciences engagements can remain identifiable even after the client name is removed. A development stage, platform, department, geography, workflow, metric, and timeline can combine into a recognizable fingerprint. We therefore treat disclosure as an evidence and permission process.

Named client evidence

Permission and fact review come first

A named client story is published only when the client relationship and disclosed facts are approved for public use. The public artifact should identify what was delivered, the relevant environment, the source of quotations and metrics, and any limitation needed to interpret the outcome.

We do not imply that a service has produced a particular result for multiple clients when the evidence supports only one case. We do not convert a private finding into a public benchmark. When a metric is observed, its scope and period should be clear. When value is modeled, it should remain labeled as a scenario rather than a result.

The current named case covers a Veeva commercial analytics implementation for Scilex Holding Company. It is not an AI Acceleration case study and is not presented as proof of outcomes from the new program. It demonstrates enterprise delivery, platform integration, data and dashboard work, and a client-approved account of commercial-operations value.

Related evidence and next steps

Public research

Sourced market evidence is not client evidence

Our research products synthesize public reports, company announcements, regulatory material, product information, and other cited sources. They help teams understand the market and identify patterns, but they do not imply that the organizations discussed are IntuitionLabs clients.

The GenAI implementation report reviews publicly described initiatives and links the reader to source material. Company names in that report identify the subject of public research, not a commercial relationship. The distinction is maintained in page copy, labels, structured data, and calls to action.

Public examples can inform a use-case portfolio, platform discussion, or risk review. They should not substitute for readiness evidence in the buyer’s environment. Workflow value depends on source information, process, review, users, tools, partners, and constraints specific to the organization.

Related evidence and next steps

Program evidence

Private results stay private until disclosure is approved

The AI Acceleration Program creates operational evidence: baselines, adoption, workflow outcomes, correction categories, exceptions, reliability, support demand, and scale decisions. Those artifacts belong to the engagement and are not automatically marketing material.

If a client later wants to share a story, the parties agree the facts, scope, denominators, timing, method, limitations, quotations, attribution, and identifying context. An anonymized case receives the same review because a distinctive combination of details can identify the company or individuals.

Until then, our public site explains the measurement method and service deliverables without inventing a result. This creates a more useful buying conversation: the buyer can evaluate how evidence will be produced without being asked to trust a composite success story.

Related evidence and next steps

Technical credibility

Inspect the implementation thinking behind the claim

Proof is also visible in the specificity of the work: how identity and permissions are enforced, how sources become authoritative, how retrieval is evaluated, how human review is designed, how changes are tested, and how a service is operated after a demonstration.

Our service pages expose these decisions and link to relevant official sources. Technical pages describe platform patterns such as Veeva integration, Egnyte MCP, hosted scientific AI, private inference, validation, and custom development. They are statements of capability and approach, not claims that every pattern has been deployed for every client.

A buyer can use the first discussion to test fit against a real workflow and environment. We will distinguish what is proven in public, what can be demonstrated, what requires discovery, what depends on a vendor, and what remains a hypothesis to measure.

Credibility increases when the boundary of the evidence is as clear as the result.

Related evidence and next steps

Define the Evidence Before the Pilot

Define the Evidence Before the Pilot

Tell us which workflow and decision matter. We will help establish the baseline, evidence boundary, review method, and scale criteria before implementation begins.

Discuss an Evidence-Led Program

© 2026 IntuitionLabs. All rights reserved.